About BrainCool
BrainCool is a publicly listed company based in Lund (Sweden) founded in 2010. Brain cooling technologies and therapeutic hypothermia devices are developed. BrainCool has completed 1 acquisition, including BeneChill. BrainCool offers products and services including BrainCool, RhinoChill, and Cooral. Its focus areas include Life Sciences, Hospital Equipment, Critical Care and Diversified. Its legal entity is BrainCool AB.
Company details
BrainCool develops medical cooling technologies with a focus on brain cooling and prevention of oral mucositis. The company offers a brain hypothermia device The BrainCool System, for the stroke market; a brain hypothermia device, The BrainCool System (with a different configuration), for the cardiac arrest market; the PolarCap System for concussion; And accessories such as the BrainCool Pads which is used for not more than 1 2 patients on a weekly basis. Therapeutic hypothermia, or cooling, lowers a patients body temperature to help reduce the risk of injury to the brain following a period of insufficient blood flow. The devices have applications in Stroke, Concussion, Ischemic stroke, oncology (prevention of oral mucositis), and cardiac arrest.
- Headquarters Lund, Sweden
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website braincool.se
- Social LinkedIn
- Legal Name Braincool Ab
- Annual Revenue$3.93 M (USD)-9.38as on Dec 31, 2025
- Net Profit-$4.02 M (USD)16.26as on Dec 31, 2025
- EBITDA-$3.96 M (USD)12.47as on Dec 31, 2025
- Latest Funding Round$1.79M (USD), Grant
Dec 2020
- Investors
- Investments & Acquisitions
Products & Services of BrainCool
BrainCool offers a comprehensive portfolio of products and services, including BrainCool, RhinoChill, and Cooral.
Device for managing body temperature in stroke and cardiac arrest cases.
Nasal device for rapid induction of therapeutic hypothermia.
Tool to reduce chemotherapy-induced mucositis in oncology.
Funding Insights of BrainCool
- Total Rounds 1
- Last Round Grant — $1.79M
- First Round $1.79M
(Dec 2020)
- Investors Count 1
All 1 funding rounds of BrainCool with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | $1.79M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in BrainCool
BrainCool has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for BrainCool
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of BrainCool
BrainCool is a publicly listed company on the OMXSTO with ticker symbol BRAIN in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 May 2014
- Listed onOMXSTO: BRAIN
- Listed entityBrainCool AB
- Exchange sectorHealth technology
- ISINSE0005731833
- Share price1.15 SEK (+0.53% on the day) · 2026-10-14
- Market capitalisation450,161,078.00 SEK
- EPS (diluted, trailing year)-0.11 SEK
- Volume (last session)52,025
Financials of BrainCool
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 36.2M SEK | -37.0M SEK | -36.5M SEK |
| 2024 | 40.0M SEK | -44.2M SEK | -41.6M SEK |
| 2023 | 23.2M SEK | -61.3M SEK | -53.1M SEK |
| 2022 | 17.6M SEK | -45.6M SEK | -46.1M SEK |
| 2021 | 9.3M SEK | -38.8M SEK | -47.8M SEK |
Detailed financial statements for BrainCool
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BrainCool
BrainCool has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BeneChill.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Non-invasive cooling technologies for acute ischemic events are developed. | benechill.com | San Diego, United States | 2004 | Oct 2016 | •••• |
Complete acquisition details for BrainCool
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BrainCool
4 dated milestones of BrainCool across 10 years, from founding to its latest funding, stage changes and deals.
- Founded BrainCool is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires BeneChill.
- Funding First funding round of $1.8M.
Web traffic of BrainCool
The website of BrainCool (braincool.se) receives about 6.4K visits a month.
- Monthly visits6.4K
▲ 293.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Braincool
Complete news archive for BrainCool
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BrainCool
BrainCool was founded in 2010 and raised its 1st funding round 10 years after it was founded.
BrainCool is headquartered in Lund, Sweden.
Annual revenue of BrainCool is $3.93M as on Dec 31, 2025.
BrainCool develops medical cooling technologies with a focus on brain cooling and prevention of oral mucositis. The company offers a brain hypothermia device The BrainCool System, for the stroke market; a brain hypothermia device, The BrainCool System (with a different configuration), for the cardiac arrest market; the PolarCap System for concussion; And accessories such as the BrainCool Pads which is used for not more than 1 2 patients on a weekly basis. Therapeutic hypothermia, or cooling, lowers a patients body temperature to help reduce the risk of injury to the brain following a period of insufficient blood flow. The devices have applications in Stroke, Concussion, Ischemic stroke, oncology (prevention of oral mucositis), and cardiac arrest.
BrainCool offers BrainCool, RhinoChill, and Cooral.
Yes, BrainCool is publicly traded on OMXSTO under the ticker symbol BRAIN.
BrainCool has made 1 acquisition, including BeneChill.
BrainCool has 1 investor. Key investors include European Union.
BrainCool operates through Braincool Ab.